Information Collection

Rapid Message Testing with Consumer Panel - Additional Testing of Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER)

IC 246208 under ICR 202206-0910-015 · OMB 0910-0695.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0695 can be found here:

2024-03-07 - Extension without change of a currently approved collection

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Cognitive Interview Guide.docx	Other-Interview Guide
Cognitive Interview Guide.docx	Other-Interview Guide
Screener.docx	Other-Screener
Screener.docx	Other-Screener
Author Manuscript - Patient Understanding of Nonmedical Terms.pdf	Other-Author Manuscript
Author Manuscript - Patient Understanding of Nonmedical Terms.pdf	Other-Author Manuscript
FDA Drug Safey Communication - Benadryl.pdf	Other-Drug Safety Communication - Be
FDA Drug Safey Communication - Benadryl.pdf	Other-Drug Safety Communication - Be
FDA Drug Safety Communication - Imodium.pdf	Other-Drug Safety Communication - Im
FDA Drug Safety Communication - Imodium.pdf	Other-Drug Safety Communication - Im
FDA Drug Safety Communication - Nasadrine.pdf	Other-Drug Safety Communication - Na
FDA Drug Safety Communication - Nasadrine.pdf	Other-Drug Safety Communication - Na
0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2021.docx OMB Approval Memo	IC Document
0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2021.docx OMB Approval Memo	IC Document

Information Collection (IC) Details

View Information Collection (IC)

IC Title:

Rapid Message Testing with Consumer Panel - Additional Testing of Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER)

Agency IC Tracking Number:

CDER

IC Status: Unchanged

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

table that charts list of instruments
Document Type	Instrument File	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Interview Guide	Cognitive Interview Guide.docx	Yes	Yes	Printable Only
Other-Screener	Screener.docx	Yes	Yes	Fillable Fileable
Other-Author Manuscript	Author Manuscript - Patient Understanding of Nonmedical Terms.pdf	Yes	Yes	Printable Only
Other-Drug Safety Communication - Benadryl	FDA Drug Safey Communication - Benadryl.pdf	Yes	Yes	Printable Only
Other-Drug Safety Communication - Imodium	FDA Drug Safety Communication - Imodium.pdf	Yes	Yes	Printable Only
Other-Drug Safety Communication - Nasadrine	FDA Drug Safety Communication - Nasadrine.pdf	Yes	Yes	Printable Only

Federal Enterprise Architecture Business Reference Module

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 750

Number of Respondents for Small Entity: 0

Affected Public: Individuals or Households

Percentage of Respondents Reporting Electronically: 100 %

table that charts list of burden
	Requested	Previously Approved
Annual Number of Responses for this IC	750	750
Annual IC Time Burden (Hours)	45	45
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
OMB Approval Memo	0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2021.docx	03/11/2021

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.